Hlavní stránka
Philips

Termíny pro vyhledávání

AngioSculpt XL PTA scoring balloon catheter

AngioSculpt XL

PTA scoring balloon catheter

IGTDASPTAXLC

Najít podobné výrobky

Designed specifically to address long, diffuse lesions commonly found in infrainguinal arteries, the AngioSculpt XL PTA scoring balloon catheter offers 360˚ of precise and effective dilatation. AngioSculpt’s smart scoring balloon technology delivers a unique combination of controlled, effective dilatation and predictable device safety.

Kontaktujte nás
  • 1. Kiesz RS, Scheinert D, Peeters PJ, et al. Results from the international registry of the AngioSculpt Scoring Balloon Catheter for the treatment of infrapopliteal disease. J Am Coll Cardiol. 2008;51:10 (suppl B);75.
  • 2. Scheinert D, Peeters P, Bosiers M, et al. Results of the multicenter first-in-man study of a novel scoring balloon catheter for the treatment of infra-popliteal peripheral arterial disease. Catheter Cardiovasc Interv. 2007;70:1034-1039.
  • 3. AngioSculpt Test Plan ST-1197 (2008), on file at AngioScore, Inc.
  • 4. Fonseca A, Costa JR, Abizaid A, et al. Intravascular ultrasound assessment of the novel AngioSculpt Scoring Balloon Catheter for the treatment of complex coronary lesions. J Invasive Cardiol. 2008;20:21-27.
  • 5. Bosiers et al, Use of the AngioSculpt Scoring Balloon for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: 1-year Outcome Vascular, Vol. 17. No. 1, pp. 29-35. 2009.
  • 6. MASCOT Presented at Veith 2009 (NYC, NY) and CRT 2010 (Washington, DC).
  • *Please refer to product labeling, including the Instructions For Use, to select the appropriate device size.

By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.

I understand